Redox proteomics: From bench to bedside

Advances in Experimental Medicine and Biology

Volumn 806, Issue , 2014, Pages 301-317

  Ckless, Karina ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYSTEINE; PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ARTICLE; HUMAN; NITROSYLATION; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; REDOX PROTEOMICS; ANIMAL; CHEMISTRY; METABOLISM; METHODOLOGY; REVIEW;

ANIMALS; CYSTEINE; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84907424092     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-06068-2_13     Document Type: Article

References (71)

1. Weerapana E et al (2010) Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature 468(7325):790-795
2. Reddie KG, Carroll KS (2008) Expanding the functional diversity of proteins through cysteine oxidation. Curr Opin Chem Biol 12(6):746-754
3. Mannick JB, Schonhoff CM (2002) Nitrosylation: the next phosphorylation? Arch Biochem Biophys 408(1):1-6
4. Leonard SE, Carroll KS (2011) Chemical 'omics' approaches for understanding protein cysteine oxidation in biology. Curr Opin Chem Biol 15(1):88-102
5. Mohr S et al (1999) Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 274(14):9427-9430
6. Martinez-Ruiz A, Lamas S (2007) Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences. Cardiovasc Res 75(2):220-228
7. Thomas JA, Poland B, Honzatko R (1995) Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch Biochem Biophys 319(1):1-9
8. Cotgreave IA, Gerdes RG (1998) Recent trends in glutathione biochemistry-glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation? Biochem Biophys Res Commun 242(1):1-9
9. Dalle-Donne I et al (2005) S-glutathionylation in human platelets by a thiol-disulfide exchange-independent mechanism. Free Radic Biol Med 38(11):1501-1510
10. Percival MD et al (1999) Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid. Biochemistry 38(41):13574-13583
11. Ji Y et al (1999) S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione. Arch Biochem Biophys 362(1):67-78
12. Cabiscol E, Levine RL (1995) Carbonic anhydrase III. Oxidative modification in vivo and loss of phosphatase activity during aging. J Biol Chem 270(24):14742-14747
13. Ward NE et al (1998) Irreversible inactivation of protein kinase C by glutathione. J Biol Chem 273(20):12558-12566
14. Cappiello M et al (1996) Specifically targeted modification of human aldose reductase by physiological disulfides. J Biol Chem 271(52):33539-33544
15. Davis DA et al (1996) Regulation of HIV-1 protease activity through cysteine modification. Biochemistry 35(7):2482-2488
16. Xian M et al (2000) Inhibition of papain by S-nitrosothiols. Formation of mixed disulfides. J Biol Chem 275(27):20467-20473
17. Klatt P, Lamas S (2002) c-Jun regulation by S-glutathionylation. Methods Enzymol 348:157-174
18. Pineda-Molina E, Lamas S (2002) S-glutathionylation of NF-kappa B subunit p50. Methods Enzymol 359:268-279
19. Reynaert NL et al (2006) Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci U S A 103(35):13086-13091
20. Shelton MD, Kern TS, Mieyal JJ (2007) Glutaredoxin regulates nuclear factor {kappa}-B and intercellular adhesion molecule in Muller cells: model of diabetic retinopathy. J Biol Chem 282(17):12467-12474
21. Gravina SA, Mieyal JJ (1993) Thioltransferase is a specific glutathionyl mixed disulfide oxidoreductase. Biochemistry 32(13):3368-3376
22. Fernando MR et al (2006) Mitochondrial thioltransferase (glutaredoxin 2) has GSH-dependent and thioredoxin reductase-dependent peroxidase activities in vitro and in lens epithelial cells. FASEB J 20(14):2645-2647
23. Su D, Gladyshev VN (2004) Alternative splicing involving the thioredoxin reductase module in mammals: a glutaredoxin-containing thioredoxin reductase 1. Biochemistry 43(38):12177-12188
24. Kerwin JF Jr, Lancaster JR Jr, Feldman PL (1995) Nitric oxide: a new paradigm for second messengers. J Med Chem 38(22):4343-4362
25. Eu JP et al (2000) An apoptotic model for nitrosative stress. Biochemistry 39(5):1040-1047
26. Stamler JS, Lamas S, Fang FC (2001) Nitrosylation. The prototypic redox-based signaling mechanism. Cell 106(6):675-683
27. Hess DT et al (2001) S-nitrosylation: spectrum and specificity. Nat Cell Biol 3(2):E46-E49
28. Mannick JB et al (1999) Fas-induced caspase denitrosylation. Science 284(5414):651-654
29. Reynaert NL et al (2004) Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci U S A 101(24):8945-8950
30. Marshall HE, Stamler JS (2001) Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40(6):1688-1693
31. Moller MN et al (2007) Acceleration of nitric oxide autoxidation and nitrosation by membranes. IUBMB Life 59(4-5):243-248
32. Wink DA et al (1993) Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O2 reaction. Chem Res Toxicol 6(1):23-27
33. Hogg N (2002) The biochemistry and physiology of S-nitrosothiols. Annu Rev Pharmacol Toxicol 42:585-600
34. Smith BC, Marletta MA (2012) Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling. Curr Opin Chem Biol 16(5-6):498-506
35. Benhar M, Forrester MT, Stamler JS (2009) Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol 10(10):721-732
36. Forrester MT et al (2009) Detection of protein S-nitrosylation with the biotin-switch technique. Free Radic Biol Med 46(2):119-126
37. Benhar M et al (2008) Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 320(5879):1050-1054
38. Sengupta R et al (2009) Nitric oxide and dihydrolipoic acid modulate the activity of caspase 3 in HepG2 cells. FEBS Lett 583(21):3525-3530
39. Ito T, Yamakuchi M, Lowenstein CJ (2011) Thioredoxin increases exocytosis by denitrosylating N-ethylmaleimide-sensitive factor. J Biol Chem 286(13):11179-11184
40. Ckless K et al (2004) In situ detection and visualization of S-nitrosylated proteins following chemical derivatization: identification of Ran GTPase as a target for S-nitrosylation. Nitric Oxide 11(3):216-227
41. Reynaert NL et al (2006) In situ detection of S-glutathionylated proteins following glutaredoxin-1 catalyzed cysteine derivatization. Biochim Biophys Acta 1760(3):380-387
42. Chouchani ET et al (2011) Proteomic approaches to the characterization of protein thiol modification. Curr Opin Chem Biol 15(1):120-128
43. Charles R, Jayawardhana T, Eaton P (2014) Gel-based methods in redox proteomics. Biochim Biophys Acta 1840(2):830-837
44. Thamsen M, Jakob U (2011) The redoxome: proteomic analysis of cellular redox networks. Curr Opin Chem Biol 15(1):113-119
45. Saurin AT et al (2004) Widespread sulfenic acid formation in tissues in response to hydrogen peroxide. Proc Natl Acad Sci U S A 101(52):17982-17987
46. Jaffrey SR, Snyder SH (2001) The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001(86):pl1
47. Chan HL, Sinclair J, Timms JF (2012) Proteomic analysis of redox-dependent changes using cysteine-labeling 2D DIGE. Methods Mol Biol 854:113-128
48. Aesif SW et al (2009) In situ analysis of protein S-glutathionylation in lung tissue using glutaredoxin-1-catalyzed cysteine derivatization. Am J Pathol 175(1):36-45
49. Leonard SE, Reddie KG, Carroll KS (2009) Mining the thiol proteome for sulfenic acid modifications reveals new targets for oxidation in cells. ACS Chem Biol 4(9):783-799
50. Charles RL et al (2007) Protein sulfenation as a redox sensor: proteomics studies using a novel biotinylated dimedone analogue. Mol Cell Proteomics 6(9):1473-1484
51. Leichert LI et al (2008) Quantifying changes in the thiol redox proteome upon oxidative stress in vivo. Proc Natl Acad Sci U S A 105(24):8197-8202
52. Valko M et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44-84
53. Lehtinen MK, Bonni A (2006) Modeling oxidative stress in the central nervous system. Curr Mol Med 6(8):871-881
54. Perry JJ, Shin DS, Tainer JA (2010) Amyotrophic lateral sclerosis. Adv Exp Med Biol 685:9-20
55. Yan LJ, Orr WC, Sohal RS (1998) Identification of oxidized proteins based on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, immunochemical detection, isoelectric focusing, and microsequencing. Anal Biochem 263(1):67-71
56. Beal MF (2002) Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32(9):797-803
57. Poon HF et al (2005) Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis. Free Radic Biol Med 39(4):453-462
58. Fraser PE, Levesque L, McLachlan DR (1993) Biochemistry of Alzheimer's disease amyloid plaques. Clin Biochem 26(5):339-349
59. Hardy J et al (2006) Tangle diseases and the tau haplotypes. Alzheimer Dis Assoc Disord 20(1):60-62
60. Binder LI et al (2005) Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta 1739(2-3):216-223
61. Williams DR (2006) Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J 36(10):652-660
62. Butterfield DA, Perluigi M, Sultana R (2006) Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol 545(1):39-50
63. Sultana R, Perluigi M, Allan Butterfield D (2013) Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med 62:157-169
64. Licker V et al (2009) Proteomics in human Parkinson's disease research. J Proteomics 73(1):10-29
65. Basso M et al (2004) Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 4(12):3943-3952
66. Werner CJ et al (2008) Proteome analysis of human substantia nigra in Parkinson's disease. Proteome Sci 6:8
67. Kumar V et al (2013) Redox proteomics of thiol proteins in mouse heart during ischemia/ reperfusion using ICAT reagents and mass spectrometry. Free Radic Biol Med 58:109-117
68. Walsh CT, Garneau-Tsodikova S, Gatto GJ Jr (2005) Protein posttranslational modifications: the chemistry of proteome diversifications. Angew Chem Int Ed Engl 44(45):7342-7372
69. Levine RL, Stadtman ER (2001) Oxidative modification of proteins during aging. Exp Gerontol 36(9):1495-1502
70. Di Domenico F et al (2011) Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits. Biochim Biophys Acta 1814(12):1785-1795
71. Marino SM, Gladyshev VN (2010) Cysteine function governs its conservation and degeneration and restricts its utilization on protein surfaces. J Mol Biol 404(5):902-916